PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 63 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,856,000 | +26.6% | 583,333 | 0.0% | 0.10% | +55.4% |
| Q2 2022 | $3,045,000 | -24.3% | 583,333 | 0.0% | 0.06% | -22.6% |
| Q1 2022 | $4,025,000 | -44.6% | 583,333 | 0.0% | 0.08% | -25.0% |
| Q4 2021 | $7,262,000 | -60.2% | 583,333 | 0.0% | 0.11% | -52.9% |
| Q3 2021 | $18,229,000 | +9.1% | 583,333 | 0.0% | 0.24% | +38.4% |
| Q2 2021 | $16,701,000 | -38.5% | 583,333 | -6.9% | 0.17% | -35.8% |
| Q1 2021 | $27,146,000 | -49.4% | 626,502 | -16.5% | 0.27% | -37.2% |
| Q4 2020 | $53,663,000 | +137.5% | 750,000 | 0.0% | 0.43% | +149.7% |
| Q3 2020 | $22,598,000 | – | 750,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |